Clinical Trials in Atlanta

Showing 14221-14240 of 19,805 trials

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

NCT01884571

This is a multicenter, 15-month study evaluating the effect of immunosuppression treatment on the rate of change on the ALS Functional Rating Scale (Revised) (ALSFRS-R) score in up to 33 subjects with Amyotrophic Lateral Sclerosis (ALS).

Amyotrophic Lateral Sclerosis (ALS)

Emory University31 participantsStarted Oct 2013

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Worcester, Massachusetts, United States

TERMINATEDPhase 2< 1 mile

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

NCT00400205

This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells.

Squamous Cell CarcinomaOral Cancer

Emory University14 participantsStarted Aug 2006

Atlanta, Georgia, United States

COMPLETEDPhase 2< 1 mile

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

NCT00068367

RATIONALE: Erlotinib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: This phase II trial is studying how well erlotinib works in treating patients with unresectable or metastatic malignant peripheral nerve sheath tumor.

Sarcoma

SWOG Cancer Research Network24 participantsStarted Dec 2003

Little Rock, Arkansas, United States • Davis, California, United States • Martinez, California, United States +98 more locations

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

Find Trials by Condition in Atlanta

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Ablation of Intestinal Metaplasia Containing Dysplasia

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

Facilitating Adolescent Self-Change for Alcohol Problems

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers